PAUL WOHLETZ: Open Payments
NPI 1356934822 · KANSAS CITY, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$696 in 25 payments from 10 companies in 2025. Trend: 2023 $775 · 2024 $1,219 · 2025 $696
Food & beverage: $696
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 6 | $317 |
| Boston Scientific Corporation | 5 | $136 |
| Novo Nordisk Inc | 3 | $65 |
| PFIZER INC. | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Amgen Inc. | 2 | $29 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| ABIOMED | 1 | $18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $16 |
Products named: AURORA EV-ICD MRI SURESCAN, FARAPULSE, COBALT DR MRI SURESCAN, LINQ II, Wegovy, ELIQUIS, ONPATTRO, FARXIGA.
Industry payments across KS — which companies pay providers there.
